These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

676 related articles for article (PubMed ID: 33788264)

  • 1. Increased B-cell activity with consumption of activated monocytes in severe COVID-19 patients.
    Kos I; Balensiefer B; Lesan V; Kaddu-Mulindwa D; Thurner L; Christofyllakis K; Bittenbring JT; Ahlgrimm M; Seiffert M; Wagenpfeil S; Bewarder Y; Neumann F; Rixecker T; Smola S; Link A; Krawczyk M; Lammert F; Lepper PM; Bals R; Stilgenbauer S; Bewarder M
    Eur J Immunol; 2021 Jun; 51(6):1449-1460. PubMed ID: 33788264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte Subset Alteration and Monocyte CD4 Expression Reduction in Patients with Severe COVID-19.
    Kazancioglu S; Yilmaz FM; Bastug A; Sakallı A; Ozbay BO; Buyuktarakci C; Bodur H; Yilmaz G
    Viral Immunol; 2021 Jun; 34(5):342-351. PubMed ID: 33264073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Longitudinal Study of Immune Cells in Severe COVID-19 Patients.
    Payen D; Cravat M; Maadadi H; Didelot C; Prosic L; Dupuis C; Losser MR; De Carvalho Bittencourt M
    Front Immunol; 2020; 11():580250. PubMed ID: 33178207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4 and CD8 Lymphocyte Counts as Surrogate Early Markers for Progression in SARS-CoV-2 Pneumonia: A Prospective Study.
    Calvet J; Gratacós J; Amengual MJ; Llop M; Navarro M; Moreno A; Berenguer-Llergo A; Serrano A; Orellana C; Cervantes M
    Viruses; 2020 Nov; 12(11):. PubMed ID: 33182268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Divergent SARS-CoV-2-specific T- and B-cell responses in severe but not mild COVID-19 patients.
    Oja AE; Saris A; Ghandour CA; Kragten NAM; Hogema BM; Nossent EJ; Heunks LMA; Cuvalay S; Slot E; Linty F; Swaneveld FH; Vrielink H; Vidarsson G; Rispens T; van der Schoot E; van Lier RAW; Ten Brinke A; Hombrink P
    Eur J Immunol; 2020 Dec; 50(12):1998-2012. PubMed ID: 33073359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical COVID-19 is associated with distinct leukocyte phenotypes and transcriptome patterns.
    Christensen EE; Jørgensen MJ; Nore KG; Dahl TB; Yang K; Ranheim T; Huse C; Lind A; Nur S; Stiksrud B; Jenum S; Tonby K; Holter JC; Holten AR; Halvorsen B; Dyrhol-Riise AM
    J Intern Med; 2021 Sep; 290(3):677-692. PubMed ID: 34080738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses.
    Zhou R; To KK; Wong YC; Liu L; Zhou B; Li X; Huang H; Mo Y; Luk TY; Lau TT; Yeung P; Chan WM; Wu AK; Lung KC; Tsang OT; Leung WS; Hung IF; Yuen KY; Chen Z
    Immunity; 2020 Oct; 53(4):864-877.e5. PubMed ID: 32791036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High CD4-to-CD8 ratio identifies an at-risk population susceptible to lethal COVID-19.
    De Zuani M; Lazničková P; Tomašková V; Dvončová M; Forte G; Stokin GB; Šrámek V; Helán M; Frič J
    Scand J Immunol; 2022 Mar; 95(3):e13125. PubMed ID: 34861051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamics of NK, CD8 and Tfh cell mediated the production of cytokines and antiviral antibodies in Chinese patients with moderate COVID-19.
    Yan L; Cai B; Li Y; Wang MJ; An YF; Deng R; Li DD; Wang LC; Xu H; Gao XD; Wang LL
    J Cell Mol Med; 2020 Dec; 24(24):14270-14279. PubMed ID: 33145962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 and Cancer: Discovery of Difference in Clinical Immune Indexes.
    Zeng X; Jiang X; Yang L; Pan Y; Li Y
    J Immunol Res; 2021; 2021():8669098. PubMed ID: 34712741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 severity associates with pulmonary redistribution of CD1c+ DCs and inflammatory transitional and nonclassical monocytes.
    Sánchez-Cerrillo I; Landete P; Aldave B; Sánchez-Alonso S; Sánchez-Azofra A; Marcos-Jiménez A; Ávalos E; Alcaraz-Serna A; de Los Santos I; Mateu-Albero T; Esparcia L; López-Sanz C; Martínez-Fleta P; Gabrie L; Del Campo Guerola L; de la Fuente H; Calzada MJ; González-Álvaro I; Alfranca A; Sánchez-Madrid F; Muñoz-Calleja C; Soriano JB; Ancochea J; Martín-Gayo E;
    J Clin Invest; 2020 Dec; 130(12):6290-6300. PubMed ID: 32784290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocyte Changes in Severe COVID-19: Delayed Over-Activation of STING?
    Berthelot JM; Lioté F; Maugars Y; Sibilia J
    Front Immunol; 2020; 11():607069. PubMed ID: 33335532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of SARS-CoV-2-specific immune alterations in acutely ill patients.
    Rébillard RM; Charabati M; Grasmuck C; Filali-Mouhim A; Tastet O; Brassard N; Daigneault A; Bourbonnière L; Anand SP; Balthazard R; Beaudoin-Bussières G; Gasser R; Benlarbi M; Moratalla AC; Solorio YC; Boutin M; Farzam-Kia N; Descôteaux-Dinelle J; Fournier AP; Gowing E; Laumaea A; Jamann H; Lahav B; Goyette G; Lemaître F; Mamane VH; Prévost J; Richard J; Thai K; Cailhier JF; Chomont N; Finzi A; Chassé M; Durand M; Arbour N; Kaufmann DE; Prat A; Larochelle C
    J Clin Invest; 2021 Apr; 131(8):. PubMed ID: 33635833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex differences in immune responses to SARS-CoV-2 in patients with COVID-19.
    Zhao G; Xu Y; Li J; Cui X; Tan X; Zhang H; Dang L
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33350432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2-specific CD8
    Roukens AHE; Pothast CR; König M; Huisman W; Dalebout T; Tak T; Azimi S; Kruize Y; Hagedoorn RS; Zlei M; Staal FJT; de Bie FJ; van Dongen JJM; Arbous SM; Zhang JLH; Verheij M; Prins C; van der Does AM; Hiemstra PS; de Vries JJC; Janse JJ; Roestenberg M; Myeni SK; Kikkert M; Yazdanbakhsh M; Heemskerk MHM; Smits HH; Jochems SP; ;
    Nat Immunol; 2022 Jan; 23(1):23-32. PubMed ID: 34937933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unique immunological profile in patients with COVID-19.
    Varchetta S; Mele D; Oliviero B; Mantovani S; Ludovisi S; Cerino A; Bruno R; Castelli A; Mosconi M; Vecchia M; Roda S; Sachs M; Klersy C; Mondelli MU
    Cell Mol Immunol; 2021 Mar; 18(3):604-612. PubMed ID: 33060840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.
    Sánchez-Ramón S; Bellón JM; Resino S; Cantó-Nogués C; Gurbindo D; Ramos JT; Muñoz-Fernández MA
    Pediatrics; 2003 Feb; 111(2):E168-75. PubMed ID: 12563091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recovery from Acute SARS-CoV-2 Infection and Development of Anamnestic Immune Responses in T Cell-Depleted Rhesus Macaques.
    Hasenkrug KJ; Feldmann F; Myers L; Santiago ML; Guo K; Barrett BS; Mickens KL; Carmody A; Okumura A; Rao D; Collins MM; Messer RJ; Lovaglio J; Shaia C; Rosenke R; van Doremalen N; Clancy C; Saturday G; Hanley P; Smith BJ; Meade-White K; Shupert WL; Hawman DW; Feldmann H
    mBio; 2021 Aug; 12(4):e0150321. PubMed ID: 34311582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Frequencies of Functional Virus-Specific CD4
    Mele D; Calastri A; Maiorano E; Cerino A; Sachs M; Oliviero B; Mantovani S; Baldanti F; Bruno R; Benazzo M; Grifoni A; Sette A; Mondelli MU; Varchetta S
    Front Immunol; 2021; 12():748881. PubMed ID: 34858405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Existence of SARS-CoV-2 in COVID-19 Patients: Host Immunity, Viral Virulence, and Transmissibility.
    Wang X; Huang K; Jiang H; Hua L; Yu W; Ding D; Wang K; Li X; Zou Z; Jin M; Xu S
    Virol Sin; 2020 Dec; 35(6):793-802. PubMed ID: 33156486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.